燒傷軟膏市場的增長,趨勢,COVID-19的影響和預測(2021-2026)
市場調查報告書
商品編碼
995769

燒傷軟膏市場的增長,趨勢,COVID-19的影響和預測(2021-2026)

Burn Ointment Market - Growth, Trends, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2020年,燒傷軟膏的市場規模為8.359億美元。

在預測期間,市場預計將以5.95%的複合年增長率增長,到2026年將達到11.764.1百萬美元。

當前的COVID-19疫情正在對市場增長產生負面影響。爆發導致尋求燒傷醫療救助的患者數量減少。此外,行業參與者減少了在該市場上研發新產品的支出。由於各個國家只允許進口和出口基本藥物,因此供應鏈也受到了乾擾。為了恢復市場增長,市場參與者有望提出新的解決方案,以解決當前的情況。

市場增長的主要驅動力是燃燒率的提高和對治療選擇的意識增強。根據世界衛生組織(WHO)2018年發佈的數據,全球每年平均有265,000人死於燒傷。這些死亡大多數發生在低收入和中等收入國家,其中一半來自東南亞。

此外,提高公眾對與燒傷相關的各種治療方法的認識也是在預測期內推動市場的重要因素。意識的提高也增加了燒傷治療的總體醫療費用。隨著人們更加積極地選擇新的高級燒傷創口護理產品,尤其是如果患者遭受燒傷,市場也將推動增長。另外,公共和私人組織還提供培訓和意識計劃,以進一步推進治療方案。例如,在2019年9月,Integra Integra生命科學公司與歐洲燒傷協會合作啟動了一項培訓計劃。該培訓計劃旨在幫助外科醫生教授燒傷治療的最佳實踐和培訓。培訓計劃的目的是為外科醫生提供有關高級燒傷治療的益處的適當知識,並提高接受治療的患者的依從性。因此,預計這些因素將在預測期內推動市場增長。然而,與燒傷藥膏相關的副作用例如皮膚壞死,瘙癢和發紅預計將成為市場上的主要限制。

該報告探索了燒傷軟膏市場,提供了市場概況,按產品類型,燒傷深度,最終用戶,地區和進入市場的公司概況的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場驅動力
    • 燒傷發生率增加
    • 提高對治療方案的認識
  • 市場限制
    • 與燒傷軟膏有關的副作用
  • 波特的五種力量分析

第5章市場細分

  • 按產品類型
    • 外用抗生素
  • 按燃燒深度
    • 輕度灼傷
    • 局部燒傷
    • III度燒傷
  • 最終用戶
    • 醫院和診所
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美洲

第6章競爭情況

  • 公司簡介
    • 3M
    • Cardinal Health
    • Cipla Limited
    • ConvaTec Group PLC
    • DeRoyal Industries, Inc.
    • Dr.Morepen
    • GlaxoSmithKline Plc
    • Intergra LifeSciences
    • Johnson & Johnson
    • Mankind Pharma
    • Perrigo Company Plc
    • Pfizer Inc
    • Smith & Nephew Plc
    • Sun Pharmaceutical Industries Ltd (Ranbaxy Laboratories Limited)
    • Trio Lifescience Pvt. Ltd.

第7章 市場機會與動向

簡介目錄
Product Code: 71795

The burn ointment market was valued at USD 831.59 million in 2020, and it is expected to reach USD 1176.71 million by 2026, registering a CAGR of 5.95% during the forecast period, 2021-2026.

The current COVID-19 outbreak has negatively affected the growth of the market. The outbreak has led to a decline in the number of patients seeking medical help for burns. In addition, the industry players have also reduced their overall expenditure on the research and development of new products in this market. The supply chain has also been disrupted, as various countries are only allowing the import and export of essential medications. It is expected that market players, in order to resume their growth in the market, will come up with a new solution to address the current scenario.

The major factors driving the growth of the market include rising incidences of burn and increasing awareness regarding treatment options. According to the data published by the World Health Organization (WHO) in 2018, globally, on average, 265,000 deaths are caused by burns every year. The majority of these deaths occur in low- to middle-income countries, and half of them occur in Southeast Asia.

Furthermore, the increasing awareness among people regarding various treatment options related to burns is also a key factor driving the market over the forecast period. Owing to the increased awareness, the overall healthcare expenditure on burn care is also increasing. The market is also growing due to the increasing willingness among people to spend more and opt for new advanced blaze wound care products, especially in the case of patients affected with burns. Apart from this, public and private organizations are also running training and awareness programs to further advance the treatment options. For instance, in September 2019, Integra LifeSciences Corporation, in collaboration with the European Burn Association, initiated a training program. The training program was organized for surgeons to inculcate the best practices and training for the treatment of burns. The aim of the training program was to provide adequate knowledge to surgeons regarding the benefit of advanced burn care and increase patient compliance during the treatment.

Thus, the above-mentioned factors are expected to drive the market growth over the forecast period. However, the side effects associated with burnt ointments, such as skin necrosis, itchy skin, redness, etc., are expected to be the major restraining factor for the market.

Key Market Trends

The Topical Antibiotics Segment is Expected to Hold a Significant Market Share Over the Forecast Period

In terms of product type, the market is segmented into topical antibiotics, silver, and iodine. The topical antibiotics segment is expected to hold a significant market share during the forecast period. The major factors propelling the growth of this segment include the high acceptance of burn ointment products in home-care settings and the rising incidence of burns across the globe. Mafenide acetate, Bacitracin, Mupirocin, Neosporin, Polymyxin B, Nitrofurazone, and Nystatin are the widely accepted topical antibiotics burn ointments. As per the Royal Australian College of General Practitioners 2017 report, stated burn injuries are common and costly. Each year, there are more than 200,000 cases, costing the Australian community USD 150 million. The management of initial burns with an ointment is usually considered effective and is preferred even with dressing or other treatments. Thus, the above-mentioned factors are expected to drive the market growth over the forecast period.

The North American Region is Expected to Hold a Major Market Share Over the Forecast Period

In the North American region, the United States is expected to hold a major market share due to well-established healthcare infrastructure and the rising incidence of burns. For instance, as per the American Burn Association 2018 report, in the United States, over 300 children are seen in emergency rooms each day, and about two children die from burn injuries. Children aged 16 years and below represent approximately 26% of all admissions to burn center hospitals in the United States. Also, according to the report published by the National Center for Biotechnology Information (NCBI), approximately 486,000 people suffer from blaze wounds every year. A high incidence of burns is likely to drive the demand for burn ointments. In addition, the presence of key players in this region that are focusing on planned initiatives like the launch of new products and mergers and acquisitions is helping the market grow. Thus, owing to the above-mentioned factors, the burn ointment market in the United States is expected to be one of the largest markets and grow in the future.

Asia-Pacific also presents lucrative opportunities in the current scenario for the key players operating in the burn ointment market due to increased patient awareness toward burn care treatment and management, increase in the number of hospitals, development of the R&D sector, rise in healthcare reforms, and increase in the target population in emerging economies.

Competitive Landscape

The burn ointment market is moderately competitive. The market players are committed to developing innovative healing solutions for customers and patients across the care continuum, generating proven clinical outcomes. The companies are also showing continuous growth and are developing new and differentiated products, which address the evolving healthcare needs among patients. Some of the market players include Johnson & Johnson, Mankind Pharma, Pfizer Inc., Dr.Morepen, Smith & Nephew PLC, and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidences of Burn
    • 4.2.2 Increasing Awareness Regarding Treatment Options
  • 4.3 Market Restraints
    • 4.3.1 Side Effects Associated with Burn Ointment
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Topical Antibiotics
    • 5.1.2 Silver
    • 5.1.3 Iodine
  • 5.2 By Depth of Burn
    • 5.2.1 Minor Burns
    • 5.2.2 Partial Thickness Burns
    • 5.2.3 Full Thickness Burns
  • 5.3 By End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 Cardinal Health
    • 6.1.3 Cipla Limited
    • 6.1.4 ConvaTec Group PLC
    • 6.1.5 DeRoyal Industries Inc.
    • 6.1.6 Dr.Morepen
    • 6.1.7 GlaxoSmithKline PLC
    • 6.1.8 Intergra LifeSciences
    • 6.1.9 Johnson & Johnson
    • 6.1.10 Mankind Pharma
    • 6.1.11 Perrigo Company PLC
    • 6.1.12 Pfizer Inc.
    • 6.1.13 Smith & Nephew PLC
    • 6.1.14 Sun Pharmaceutical Industries Ltd (Ranbaxy Laboratories Limited)
    • 6.1.15 Trio Lifescience Pvt. Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

8 IMPACT OF COVID-19 ON THE MARKET